<DOC>
	<DOCNO>NCT01847781</DOCNO>
	<brief_summary>The aim study immune response conjugate pneumococcal vaccination ( Prevenar13 ) Immunoglobulin G-deficient patient healthy control . Our hypothesis antibody response impair patient compare control . In contrast , postulate cellular immune response intact .</brief_summary>
	<brief_title>PNEUMOCELL - Conjugated Pneumococcal Vaccination Patients With Immunoglobulin G-deficiency</brief_title>
	<detailed_description>Ten patient Immunoglobulin G1 and/or Immunoglobulin G2 deficiency enrol together 10 age sex- match control . Blood-samples draw base-line 1 , 2 4 week post-vaccination . Serum analyze opsonophagocytic antibody . Peripheral blood monocytic cell ( PBMCs ) isolate , frozen later analyze time-points simultaneously . PBMCs stimulate vaccine-antigens 3-5 day cellular activation marker measure together cytokine ( Interferon-gamma , Interleukin ( IL ) -5 , IL-13 , IL-10 , IL-17 , IL-22 ) . In addition , level antimicrobial peptide nasal fluid measure baseline 4 week post-vaccination .</detailed_description>
	<mesh_term>IgG Deficiency</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<criteria>Immunoglobulin gammadeficiency : Immunoglobulin gamma 1deficiency &lt; 2,8 g/L and/or Immunoglobulin gamma 2deficiency &lt; 1,15 g/L Age 1865 Immunoglobulin gammasubstitution 6 month prior study inclusion Prevenar7 Prevenar13 give prior study inclusion . Pneumovax give 2 year period prior study inclusion Pregnancy plan become pregnant study period ( 4 week ) Taking part another clinical study involve drug vaccination study period ( 4 week ) . Taking systemic steroid , Non steroidal anti inflammatory drug ( NSAID ) immunosuppressive drug . Being allergic substance vaccine . Acute ongoing disease high fever . Thrombocytopenia ( &lt; 100x109/L ) . Coagulopathy Breastfeeding baby The healthy control disease effect immunesystem</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Opsonophagocytic antibody</keyword>
	<keyword>Cellular immunity</keyword>
	<keyword>Vaccine immunity</keyword>
	<keyword>Antimicrobial peptide</keyword>
</DOC>